6505--Radiopharmaceuticals | VA San Diego | Base Year

Description

{"description":"This amendment to solicitation 36C26226Q0072 shall answer questions.\nAll other terms and conditions remain unchanged. \nThe solicitation shall close on 11/10/2025 at 0900 PT local time. \n\nQuestion: For the I-131 DX and TX caps, do you want the dollar amount to be listed per mCi, or as the total dollar amount for the activity requested (i.e. 4mCi and 150mCi capsules?)\nAnswer: The hospital will order different doses so please provide pricing per mCi. \n\nQuestion: The price of GA68 Dotatate (NETSPOT) is dictated by the manufacturer and updated on a quarterly basis. How we handle any price adjustments set by the manufacturer (i.e. do we have to ask for a contract amendment if Novartis changes the price during the contract period?)\nAnswer: This is a firm fixed price contract. \n\n\n"} Solicitation Number: 36C26226Q0072 Type: Combined Synopsis/Solicitation Base Type: Combined Synopsis/Solicitation NAICS: 325412 Classification Code: 6505 Response Deadline: 2025-11-10T09:00:00-08:00 Office Address: Gilbert, AZ POC: Adrienne Brown, adrienne.brown4@va.gov, 951-601-4536 {"description":"This amendment to solicitation 36C26226Q0072 shall answer questions.\nAll other terms and conditions remain unchanged. \nThe solicitation shall close on 11/10/2025 at 0900 PT local time. \n\nQuestion: For the I-131 DX and TX caps, do you want the dollar amount to be listed per mCi, or as the total dollar amount for the activity requested (i.e. 4mCi and 150mCi capsules?)\nAnswer: The hospital will order different doses so please provide pricing per mCi. \n\nQuestion: The price of GA68 Dotatate (NETSPOT) is dictated by the manufacturer and updated on a quarterly basis. How we handle any price adjustments set by the manufacturer (i.e. do we have to ask for a contract amendment if Novartis changes the price during the contract period?)\nAnswer: This is a firm fixed price contract. \n\n\n"}